SOX9 and osteosarcoma: For example, low expression of miR-1225-5p is correlated with poor prognosis in patients with osteosarcoma, and its overexpression inhibits osteosarcoma cell invasion and metastasis by targeting Sox9 (Zhang et al., 2020).